Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
Schwerzmann et al.1 found that closure of patent foramen ovale (PFO) reduced the frequency of attacks by >50% in migraine patients with aura (MA+) and without aura (MA−). These authors suggest PFO closure for prophylaxis of migraine and recommend a prospective trial.
The incidence of migraine headache in patients in the year prior to PFO closure was twice the expected prevalence.1 Stress is one of the most common precipitants of migraine attacks.2 The cerebral and peripheral events associated with PFO in these patients1 are significant medical occurrences correctable only by invasive intervention. To exclude event-related stress, the incidence of migraine attacks prior to the event, diagnosis of PFO, or both, must be determined.
Secondly, the >50% reduction of migraine attacks following PFO closure1 is statistically significant but biologically debatable. The placebo responsiveness of patients with migraine is increased. Inclusion of migraine patients with as few as two attacks per month in the …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Prevalence and size of directly detected patent foramen ovale in migraine with auraM. Schwerzmann, K. Nedeltchev, F. Lagger et al.Neurology, September 07, 2005 -
Articles
Recurrent cerebral ischemia in medically treated patent foramen ovaleA meta-analysisM. A. Almekhlafi, S. B. Wilton, D. M. Rabi et al.Neurology, May 13, 2009 -
Brief Communications
Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacksM. Schwerzmann, S. Wiher, K. Nedeltchev et al.Neurology, April 26, 2004 -
Brief Communications
Different degrees of right-to-left shunting predict migraine and stroke: Data from 420 patientsGian Paolo Anzola, Eva Morandi, Francesco Casilli et al.Neurology, March 13, 2006